Baxter International Looks At Reducing Hospital Infection Rates In China
This article was originally published in PharmAsia News
Executive Summary
Baxter International recently hosted a forum in Beijing, where Baxter's Chief Scientific Officer Norbert Riedel and local experts shared their experiences on how to reduce hospital infections, which affect 10 percent of hospitalized patients in China. Riedel revealed that the company has looked into drug application safety issues and various methods of controlling hospital infections. These cover the procedure and management of intravenous infusions, including Baxter's closed drug dispensing system, premixed drugs, intravenous infusion bags and antimicrobial-coated IV connectors. Baxter has set up a premixed drug R&D center to develop products suitable for the local market. New premixed drugs are expected to be launched next year, which will elevate China's level of research and application in the field. (Click here for more - Chinese Language)
|
Baxter International recently hosted a forum in Beijing, where Baxter's Chief Scientific Officer Norbert Riedel and local experts shared their experiences on how to reduce hospital infections, which affect 10 percent of hospitalized patients in China. Riedel revealed that the company has looked into drug application safety issues and various methods of controlling hospital infections. These cover the procedure and management of intravenous infusions, including Baxter's closed drug dispensing system, premixed drugs, intravenous infusion bags and antimicrobial-coated IV connectors. Baxter has set up a premixed drug R&D center to develop products suitable for the local market. New premixed drugs are expected to be launched next year, which will elevate China's level of research and application in the field. (Click here for more - Chinese Language) "Baxter International Chief Scientist And Experts Discuss How To Reduce Hospital Infection" - sohu.com (11/6/08) |